Chicken Sandwich Proxy Battle Playing Out Over MSG Use
McDonald’s Corp (NYSE:MCD) is testing a new chicken sandwich across three states and the National Owners Association is…
Ironwood And Allergan Announce Settlement With Teva Resolving LINZESS Patent Litigation; Settlement Does Not Grant License To Teva With Regard To 72 mcg Generic Version Of LINZESS, Grants Teva License To Market 145 mcg And 290 mcg Generics Starting 202…
– Settlement with Teva represents final outstanding LINZESS patent litigation – – The earliest licensed entry of any…
Freight Transportation Stakeholders Grapple With Big Uncertainties
Stakeholders participating in today’s global supply chain must grapple with three big themes: the growing impact of e-commerce,…
Jacobs To Exit Most Of XPO The Way He Entered — Unconventionally
Brad Jacobs didn't build XPO Logistics Inc. (NYSE:XPO) the traditional way. He's not taking it apart the traditional…
Neovasc Highlights Presentations Across Germany Featuring Co.’s Reducer Product
Neovasc, Inc.(“Neovasc” or the “Company”) (NASDAQ,TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve…
Neurotrope Awarded $2.7M In Funding By National Institute Of Health To Support Phase 2 Alzheimer’s Study
Analysis to adjust for significant baseline imbalance in Severe Impairment Battery scores between treatment groups shows improvement in…
Uber Freight Taps Amazon Alum Christenson To Run Europe
In his first 24 hours on the job, the new head of Uber Freight Europe spoke about his…
United Airlines Posts Strong Profits Despite MAX Headwinds
United Airlines’ (NASDAQ:UAL) fourth-quarter cargo revenue fell 5.4% from a year ago to $316 million, but overall revenue…
Is This The End Of XPO As We Know It?
On EP12, Kevin and Andrew sit with Director of Passport Research JP Hampstead to discuss what lies ahead…
Akcea And Ionis Report Topline Phase 2 Results Of AKCEA-APOCIII-L Rx; Primary And Key Secondary Endpoints Were Met With ‘Significant Reduction’ In apoC-III And Triglyceride Levels
Favorable safety and tolerability were demonstrated in hypertriglyceridemia patients in the study Primary and key secondary endpoints were…